
- 1D
- 1W
- 1M
- 1Y
- 5Y
- YTD
About PDS Biotechnology
PDS Biotechnology Corp operates as a clinical-stage biotechnology company. The Company develops immuno-oncology therapies to treat various early and late stage cancers including head and neck, prostate, breast, cervical, and anal cancers. PDS Biotechnology serves patients worldwide.
Stock Analysis

last close
$3.7
1-mo return
-26.6%
3-mo return
-41.9%
avg daily vol.
1.6M
52-week high
17.85
52-week low
2.91
market cap.
$95M
forward pe
-
annual div.
-
roe
-55.7%
ltg forecast
-
dividend yield
-
annual rev.
$--
inst own.
20.7%